Polarean Imaging (GB:POLX) has released an update.
Polarean Imaging PLC has appointed Dr. Chase Hall as Chief Medical Advisor, bringing his extensive pulmonary expertise to enhance the company’s medical engagement and Xenon MRI clinical development. Dr. Hall’s association with the University of Kansas and his research in imaging biomarkers for respiratory disease will support Polarean’s commitment to addressing unmet needs in pulmonary care. The company, a leader in advanced MRI lung function imaging, continues to innovate with its FDA-approved XENOVIEW technology, aiming to improve global respiratory healthcare.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
